Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients

PURPOSE: To study ocular surface disease (OSD) changes after switching from preserved prostaglandin analogues monotherapy to preserved tafluprost and preservative-free (PF) tafluprost in primary open-angle glaucoma patients. METHODS: Glaucoma patients treated with preserved prostaglandins (except ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruangvaravate, Ngamkae, Choojun, Karnthida, Srikulsasitorn, Benjawan, Chokboonpiem, Jatupol, Asanatong, Dechathon, Trakanwitthayarak, Supaporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548342/
https://www.ncbi.nlm.nih.gov/pubmed/33116362
http://dx.doi.org/10.2147/OPTH.S264984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548342/
https://www.ncbi.nlm.nih.gov/pubmed/33116362
http://dx.doi.org/10.2147/OPTH.S264984

Ejemplares similares